Videos

Nu.Q® Discover – Markets & Markets Next-Gen Immuno-Oncology Conference

March 08, 2024

Share
Tweet
Share on Facebook
Share

Screenshot 2024-03-08 132535

Volition attends Markets and Markets Next-Gen Immuno-Oncology Conference

Volition attended the Markets and Markets Next-Gen Immuno-Oncology Conference in London, March 2024. Hear from Dharmik Rawal, Volition Director Strategy & Product Launches, about how the conference went and the scope of our Nu.Q^{^®} Discover programme.

Related Articles

Poster & Publications
Circulating H3K27me3 modified nucleosomes as a biomarker to monitor anti EZH2-based treatment in advanced solid tumour patients
Poster & Publications
Novel ctDNA technology for early cancer detection by immunoprecipitation of tumor associated ctDNA fragments and analysis by qPCR

Share
Tweet
Share on Facebook
Share

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

"*" indicates required fields

Receive product updates for:

Animal Health

Human Health

Name

First Name Last Name

Company Name*

Your Email Address*

CAPTCHA